AIGEN INVESTMENT MANAGEMENT, LP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$657,260
+85.1%
16,019
+79.7%
0.10%
+56.5%
Q2 2021$355,000
-85.3%
8,912
-79.2%
0.06%
-80.3%
Q4 2020$2,417,000
+695.1%
42,747
+568.1%
0.32%
+707.7%
Q3 2020$304,000
-77.3%
6,398
-71.9%
0.04%
-77.3%
Q2 2020$1,342,000
-19.5%
22,765
-35.4%
0.17%
-22.2%
Q1 2020$1,667,000
+149.6%
35,254
+218.9%
0.22%
+99.1%
Q4 2019$668,00011,0550.11%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders